LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that Synta will present multiple posters at the American Association for Cancer Research (AACR) 102nd Annual Meeting 2011 to be held April 2-6, 2011 in Orlando, FL. The presentations will include three posters on ganetespib (STA-9090), a potent inhibitor of Hsp90 and two posters on elesclomol, a small-molecule mitochondria metabolism inhibitor.
